Report Detail

Pharma & Healthcare Global Human Chorionic Gonadotropin (HCG) Market Professional Survey Report 2019

  • RnM3806933
  • |
  • 07 October, 2019
  • |
  • Global
  • |
  • 103 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

The global Human Chorionic Gonadotropin (HCG) market was valued at 390 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025.
This report focuses on Human Chorionic Gonadotropin (HCG) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Chorionic Gonadotropin (HCG) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Human Chorionic Gonadotropin (HCG) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Human Chorionic Gonadotropin (HCG) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Natural Source Extraction
Recombinant DNA Technology

Segment by Application
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Human Chorionic Gonadotropin (HCG)

      • 1.1 Definition of Human Chorionic Gonadotropin (HCG)
      • 1.2 Human Chorionic Gonadotropin (HCG) Segment by Type
        • 1.2.1 Global Human Chorionic Gonadotropin (HCG) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Natural Source Extraction
        • 1.2.3 Recombinant DNA Technology
      • 1.3 Human Chorionic Gonadotropin (HCG) Segment by Applications
        • 1.3.1 Global Human Chorionic Gonadotropin (HCG) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Female Infertility Treatment
        • 1.3.3 Oligospermic Treatment
        • 1.3.4 Cryptorchidism Treatment
        • 1.3.5 Others
      • 1.4 Global Human Chorionic Gonadotropin (HCG) Overall Market
        • 1.4.1 Global Human Chorionic Gonadotropin (HCG) Revenue (2014-2025)
        • 1.4.2 Global Human Chorionic Gonadotropin (HCG) Production (2014-2025)
        • 1.4.3 North America Human Chorionic Gonadotropin (HCG) Status and Prospect (2014-2025)
        • 1.4.4 Europe Human Chorionic Gonadotropin (HCG) Status and Prospect (2014-2025)
        • 1.4.5 China Human Chorionic Gonadotropin (HCG) Status and Prospect (2014-2025)
        • 1.4.6 Japan Human Chorionic Gonadotropin (HCG) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Human Chorionic Gonadotropin (HCG) Status and Prospect (2014-2025)
        • 1.4.8 India Human Chorionic Gonadotropin (HCG) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Human Chorionic Gonadotropin (HCG)
      • 2.3 Manufacturing Process Analysis of Human Chorionic Gonadotropin (HCG)
      • 2.4 Industry Chain Structure of Human Chorionic Gonadotropin (HCG)

      3 Development and Manufacturing Plants Analysis of Human Chorionic Gonadotropin (HCG)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Human Chorionic Gonadotropin (HCG) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Human Chorionic Gonadotropin (HCG)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Human Chorionic Gonadotropin (HCG) Production and Capacity Analysis
      • 4.2 Human Chorionic Gonadotropin (HCG) Revenue Analysis
      • 4.3 Human Chorionic Gonadotropin (HCG) Price Analysis
      • 4.4 Market Concentration Degree

      5 Human Chorionic Gonadotropin (HCG) Regional Market Analysis

      • 5.1 Human Chorionic Gonadotropin (HCG) Production by Regions
        • 5.1.1 Global Human Chorionic Gonadotropin (HCG) Production by Regions
        • 5.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Regions
      • 5.2 Human Chorionic Gonadotropin (HCG) Consumption by Regions
      • 5.3 North America Human Chorionic Gonadotropin (HCG) Market Analysis
        • 5.3.1 North America Human Chorionic Gonadotropin (HCG) Production
        • 5.3.2 North America Human Chorionic Gonadotropin (HCG) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Human Chorionic Gonadotropin (HCG) Import and Export
      • 5.4 Europe Human Chorionic Gonadotropin (HCG) Market Analysis
        • 5.4.1 Europe Human Chorionic Gonadotropin (HCG) Production
        • 5.4.2 Europe Human Chorionic Gonadotropin (HCG) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Human Chorionic Gonadotropin (HCG) Import and Export
      • 5.5 China Human Chorionic Gonadotropin (HCG) Market Analysis
        • 5.5.1 China Human Chorionic Gonadotropin (HCG) Production
        • 5.5.2 China Human Chorionic Gonadotropin (HCG) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Human Chorionic Gonadotropin (HCG) Import and Export
      • 5.6 Japan Human Chorionic Gonadotropin (HCG) Market Analysis
        • 5.6.1 Japan Human Chorionic Gonadotropin (HCG) Production
        • 5.6.2 Japan Human Chorionic Gonadotropin (HCG) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Human Chorionic Gonadotropin (HCG) Import and Export
      • 5.7 Southeast Asia Human Chorionic Gonadotropin (HCG) Market Analysis
        • 5.7.1 Southeast Asia Human Chorionic Gonadotropin (HCG) Production
        • 5.7.2 Southeast Asia Human Chorionic Gonadotropin (HCG) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Human Chorionic Gonadotropin (HCG) Import and Export
      • 5.8 India Human Chorionic Gonadotropin (HCG) Market Analysis
        • 5.8.1 India Human Chorionic Gonadotropin (HCG) Production
        • 5.8.2 India Human Chorionic Gonadotropin (HCG) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Human Chorionic Gonadotropin (HCG) Import and Export

      6 Human Chorionic Gonadotropin (HCG) Segment Market Analysis (by Type)

      • 6.1 Global Human Chorionic Gonadotropin (HCG) Production by Type
      • 6.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Type
      • 6.3 Human Chorionic Gonadotropin (HCG) Price by Type

      7 Human Chorionic Gonadotropin (HCG) Segment Market Analysis (by Application)

      • 7.1 Global Human Chorionic Gonadotropin (HCG) Consumption by Application
      • 7.2 Global Human Chorionic Gonadotropin (HCG) Consumption Market Share by Application (2014-2019)

      8 Human Chorionic Gonadotropin (HCG) Major Manufacturers Analysis

      • 8.1 EMD Serono, Inc
        • 8.1.1 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.1.2 EMD Serono, Inc Product Introduction, Application and Specification
        • 8.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Ferring B.V
        • 8.2.1 Ferring B.V Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.2.2 Ferring B.V Product Introduction, Application and Specification
        • 8.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck & Co., Inc
        • 8.3.1 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.3.2 Merck & Co., Inc Product Introduction, Application and Specification
        • 8.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Bristol Myers Squibb Company
        • 8.4.1 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.4.2 Bristol Myers Squibb Company Product Introduction, Application and Specification
        • 8.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Fresenius Kabi AG, LLC
        • 8.5.1 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.5.2 Fresenius Kabi AG, LLC Product Introduction, Application and Specification
        • 8.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Scrippslabs
        • 8.6.1 Scrippslabs Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.6.2 Scrippslabs Product Introduction, Application and Specification
        • 8.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Leebio
        • 8.7.1 Leebio Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.7.2 Leebio Product Introduction, Application and Specification
        • 8.7.3 Leebio Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Kamiya Biomedical Company
        • 8.8.1 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.8.2 Kamiya Biomedical Company Product Introduction, Application and Specification
        • 8.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Sanzyme
        • 8.9.1 Sanzyme Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.9.2 Sanzyme Product Introduction, Application and Specification
        • 8.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Cigna
        • 8.10.1 Cigna Human Chorionic Gonadotropin (HCG) Production Sites and Area Served
        • 8.10.2 Cigna Product Introduction, Application and Specification
        • 8.10.3 Cigna Human Chorionic Gonadotropin (HCG) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Human Chorionic Gonadotropin (HCG) Market

      • 9.1 Global Human Chorionic Gonadotropin (HCG) Market Trend Analysis
        • 9.1.1 Global Human Chorionic Gonadotropin (HCG) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Human Chorionic Gonadotropin (HCG) Regional Market Trend
        • 9.2.1 North America Human Chorionic Gonadotropin (HCG) Forecast 2019-2025
        • 9.2.2 Europe Human Chorionic Gonadotropin (HCG) Forecast 2019-2025
        • 9.2.3 China Human Chorionic Gonadotropin (HCG) Forecast 2019-2025
        • 9.2.4 Japan Human Chorionic Gonadotropin (HCG) Forecast 2019-2025
        • 9.2.5 Southeast Asia Human Chorionic Gonadotropin (HCG) Forecast 2019-2025
        • 9.2.6 India Human Chorionic Gonadotropin (HCG) Forecast 2019-2025
      • 9.3 Human Chorionic Gonadotropin (HCG) Market Trend (Product Type)
      • 9.4 Human Chorionic Gonadotropin (HCG) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Human Chorionic Gonadotropin (HCG) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Human Chorionic Gonadotropin (HCG). Industry analysis & Market Report on Human Chorionic Gonadotropin (HCG) is a syndicated market report, published as Global Human Chorionic Gonadotropin (HCG) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Human Chorionic Gonadotropin (HCG) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,793.00
        4,189.50
        5,586.00
        3,265.50
        4,898.25
        6,531.00
        538,160.00
        807,240.00
        1,076,320.00
        292,110.00
        438,165.00
        584,220.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report